• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    AZ`s Luxomiti (Moxetumomab pasudotox tdfk) Receives Supp. Approval in US

    FDA

    AZ`s Lumoxiti (Moxetumomab Pasudotox TDFK) Receives Supplemental Approval in US

    FDA

    EMA Accepts Regulatory Submission For Lumoxiti In Relapsed Or Refractory HCL

    NASDAQ

    AstraZeneca`s Calquence treads on Imbruvica`s turf with second phase 3 CLL win

    FIERCE PHARMA

    AZ vet Jennifer Butler takes charge of Innate Pharma’s US biz; C4 raids NIBR

    ENDPTS

    Innate`s hires Jennifer Butlers to commercialisation of leukaemia drug Lumoxiti

    PHARMAFILE

    Astrazeneca`s Lumoxiti (Moxetumomab Pasudotox-Tdfk) Receives Approval in US

    FDA

    AstraZeneca lays off 210 workers in Colorado as it closes 2 ex-Amgen plants

    FIERCE PHARMA

    AstraZeneca digs deeper into cancer with Innate stake

    REUTERS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.